论文部分内容阅读
空腹血糖受损(IFG)是早期诊治糖尿病及预防心血管并发症的有效参考指标,它与糖耐量受损(IGT)一样均是由正常糖耐量向糖尿病(DM)转化的过渡阶段,此阶段为可逆阶段,对于临床早期防治影响深远。人们对IFG的认识不断深入,世界两大权威组织对IFG诊断标准的确立各持已见,国内外大量实验积极探讨以求尽早制定出兼具敏感性和特异性的诊断标准。
Impaired Fasting Glucose (IFG) is an effective reference for the early diagnosis and treatment of diabetes mellitus and prevention of cardiovascular complications. Like Impaired Glucose Tolerance (IGT), impaired fasting glucose (IFG) is a transitional stage from the conversion of normal glucose tolerance to diabetes mellitus (DM) As a reversible stage, far-reaching impact on the prevention and treatment of clinical early. As people’s understanding of IFG deepens, the two major authoritative organizations in the world hold their own opinions on the establishment of diagnostic criteria for IFG. A large number of experiments both at home and abroad have been actively explored in order to formulate diagnostic criteria with both sensitivity and specificity as early as possible.